Coagulation Disorders Disease 1° Bleeding Disorders Hemophilia a Hemophilia

2
Coagulation Disorders Disease Defect Characteristics 1 ° Bleeding Disorders Hemophilia A Factor VIII deficiency Can’t activate thrombin can’t clot Hemophilia B Factor IX deficiency “Christmas dz” – Can’t activate thrombin can’t clot -Platelet related vo nWille br and Dis ea se vo nWil le br and Factor  vWF can’t attach to collagen platelets can’t attach injury site Bernard Soulier Syndrome GPIbα (vWF receptor) Platelets can’t attach to vWF Glanzman Thrombasthenia GPIIb-IIIa (fibrinogen receptor) Platelets can’t aggregate can’t make stable clots 2 ° Bleeding Disorders Vit amin K Def icie nc y Gl utamic ac id re si du es not add ed to factors Liver can’t produce prothrombin, factors VII, IX, X, or Protein C no coagulation reaction Liver Disease Liver can’t produce clotting factors Problems with coagulation reaction Thrombocytopenia Platelet count Bleeding from smaller vessels Punctate hemorrhages throughout body Thrombophilia Factor V Leiden APC cant degrade factor V Increased risk to devo venous thrombosis Protein C deficiency amt APC degradation of Factors V, VIII Protein S deficiency Less APC-S complex degradation of Factors V, VIII Hypercoagulability Cancer Expression of tissue factor on surface Could trigger thromboses Pregnancy ↑↑ coagulation system to prepare for parturition Diabetes Mellitus Retinopathies d/t activation of  coagulation Obesity PAI-1 Inhibits plasminogen activity Inflammation Sepsis Stasis Blood flow Accumulation of coagulation factors in small area

Transcript of Coagulation Disorders Disease 1° Bleeding Disorders Hemophilia a Hemophilia

8/14/2019 Coagulation Disorders Disease 1° Bleeding Disorders Hemophilia a Hemophilia

http://slidepdf.com/reader/full/coagulation-disorders-disease-1-bleeding-disorders-hemophilia-a-hemophilia 1/2

Coagulation Disorders

Disease Defect Characteristics

1° Bleeding Disorders

Hemophilia A Factor VIII deficiency Can’t activate thrombin ∴ can’t clot

Hemophilia B Factor IX deficiency “Christmas dz” – Can’t activate thrombin ∴ can’t clot

-Platelet related

vonWillebrand Disease vonWillebrand Factor  vWF can’t attach to collagen ∴ platelets can’t attach injury site

Bernard Soulier 

SyndromeGPIbα (vWF receptor) Platelets can’t attach to vWF

Glanzman

Thrombasthenia

GPIIb-IIIa (fibrinogen receptor) Platelets can’t aggregate ∴ can’t make stable clots

2° Bleeding Disorders

Vitamin K Deficiency Glutamic acid residues not added to

factors

Liver can’t produce prothrombin, factors VII, IX, X, or Protein C

∴ no coagulation reactionLiver Disease Liver can’t produce clotting factors Problems with coagulation reaction

Thrombocytopenia ↓ Platelet count Bleeding from smaller vessels ∴ Punctate hemorrhages

throughout body

Thrombophilia

Factor V Leiden APC can’t degrade factor V Increased risk to devo venous thrombosis

Protein C deficiency ↓ amt APC ↓ degradation of Factors V, VIII

Protein S deficiency Less APC-S complex ↓ degradation of Factors V, VIII

Hypercoagulability

Cancer Expression of tissue factor on

surface

Could trigger thromboses

Pregnancy ↑↑ coagulation system to prepare

for parturition

Diabetes Mellitus Retinopathies d/t activation of coagulation

Obesity ↑ PAI-1 Inhibits plasminogen activity

Inflammation

SepsisStasis ↓ Blood flow Accumulation of coagulation factors in small area

8/14/2019 Coagulation Disorders Disease 1° Bleeding Disorders Hemophilia a Hemophilia

http://slidepdf.com/reader/full/coagulation-disorders-disease-1-bleeding-disorders-hemophilia-a-hemophilia 2/2

Coagulation System Testing

Test* Procedure

Whole Blood Clotting Time Collect blood. Invert every 30 sec. until clot forms. Norm = 6-10 min

Bleeding Time Cut and time to stoppage of bleeding. Norm = 1-6 min

PT – Prothrombin Time Oxalate blood. Add excess Ca+2 and tissue factor. Time to clot. Norm = 12 sec

Indication of prothrombin in blood – Estimates common pathwayPTT – Partial Thromboplastin Time Oxalate blood. Add excess Ca+2, kaolin, phospholipid. Time to clot.

“partial” b/c NO tissue factor Estimates intrinsic and extrinsic factors

TT – Thrombin Time Add thrombin, Ca+2

Estimates fibrinogen function

Platelet Aggregation Add agonist/activator. Measure clumping optically

*Measured in seconds. Expressed as INR 

DrugsName Action

Anticoagulant

Coumadin, Warfarin Inhibit γ -carboxylation of Vitamin K dependent cofactors

 Heparin ↑ antithrombin activity (↑ TAT-complexes)

 Hirudin (synthetic version=hirulog) Inhibit thrombin

Antiplatelet

GPIIb-IIIa blocking Ab, RGD-mimetic Block fibrinogen receptor (GPIIb-IIIa)

 Aspirin, indomethecin - Cyclooxygenase (COX) inhibitor 

Steroids - Phospholipase inhibitor 

Inhibit thromboxane (TXA2) synthesis

Ticlopidine, Clopidogrel  Block ADP receptor 

Fibrinolytic

TPA (Tissue Plasminogen Activator_ 

Streptokinase (Plasminogen activator)

Clot lysis

 Italics = highlighted in notes